ProUroCare Net Tangible Assets from 2010 to 2025
| PUMD Stock | USD 0.0002 0.00 0.00% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter -4.4 M | Current Value -4.6 M | Quarterly Volatility 395.2 K |
Check ProUroCare Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProUroCare Medical's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 1.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. ProUroCare financial statements analysis is a perfect complement when working with ProUroCare Medical Valuation or Volatility modules.
ProUroCare | Net Tangible Assets | Build AI portfolio with ProUroCare Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ProUroCare Medical is a strong investment it is important to analyze ProUroCare Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ProUroCare Medical's future performance. For an informed investment choice regarding ProUroCare Stock, refer to the following important reports:Check out the analysis of ProUroCare Medical Correlation against competitors. For information on how to trade ProUroCare Stock refer to our How to Trade ProUroCare Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProUroCare Medical. If investors know ProUroCare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProUroCare Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProUroCare Medical is measured differently than its book value, which is the value of ProUroCare that is recorded on the company's balance sheet. Investors also form their own opinion of ProUroCare Medical's value that differs from its market value or its book value, called intrinsic value, which is ProUroCare Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProUroCare Medical's market value can be influenced by many factors that don't directly affect ProUroCare Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProUroCare Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProUroCare Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProUroCare Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.